Home > Drug Search >
  • company_query: Betagenon
  •   > 
Drug Filter
Status:
Approved (2) Phase Ⅲ (1) Phase Ⅱ (11) Phase Ⅰ (9) IND Filing (3)
Clinical Stage:
Pending (4) Active (14) Discontinued (3)
Indication:
Non-alcoholic steatohepatitis (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Angina pectoris (1) Asthma (1) Breast cancer (1) Crohn's disease (2) Cystic fibrosis (CF) (1) Dyslipidemia (1) Gastric cancer (1) Glaucoma (1) HBV infection (1) HIV infection (1) Hypertension (1) Hypertriglyceridemia (1) Neuropathic pain (4) Non small cell lung cancer (NSCLC) (2) Obesity (1) Osteoarthritis (OA) (1) Peripheral arterial disease (PAD) (1) Postmenopausal osteoporosis (1) Psoriasis (1) Rheumatoid arthritis (RA) (1) Sjoegren's syndrome (1) Stable plaque psoriasis (1) Tinnitus (1) Type 2 diabetes (3) Head and neck cancer (1) Colorectal cancer (1) Relapsed or refractory malignant lymphoma (1) Biliary cancer (1) Contraception (1) Gram-positive bacterial infection (1) Gram-negative bacterial infection (1) Hepatic fibrosis (1) Gout (1) Vasomotor symptoms (1) Postmenopausal syndrome (1) Skin hypertrophic scars (1) Infectious disease (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top